Thyroid receptor antagonists for the treatment of cardiac...

Details Thyroid receptor antagonists for the treatment of cardiac... Thyroid receptor antagonists for the treatment of cardiac...

2008-01-15

2008-01-15

Puttlitz, Karl (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Phosphorus acids or salts thereof

C562S010000, C562S041000, C562S426000, C562S621000, C560S080000

Reexamination Certificate

active

11166821

ABSTRACT:
This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyrodism.

REFERENCES:
patent: 3586713 (1971-06-01), Buu-Hoietal
patent: 3789070 (1974-01-01), Aldo
patent: 0257 828 (1988-02-01), None
patent: 0 512 352 (1992-11-01), None
patent: 5 837 (1968-03-01), None
patent: WO 97 28137 (1997-08-01), None
Silverman, “The Organic Chemistry of Drug Design and Drug Action”, 1992, pp. 19-23.
Kametani et al., Journal of Organic Chemistry (1968), 33(2), 690-4.
Barnes et al. Journal of the Chemical Society (1953) 764-77, CAS online citation [retrieved Oct. 16, 2006] Columbus, OH, USA.
Bhalerao et al, Synthetic Communications, (1995), 25 (10, pp. 1433-1439, CA document No. 123:227752.
Lacourciere, Gerard M.: “Selenium Is Mobilized In Vivo from Free Selenocysteine and Is Incorporated Specifically into Formate Dehydrogenase H and tRNA Nucleosides”,Journal of Bacteriology, vol. 184, No. 7, pp. 1040-1946 (Apr. 2002).
“Brassica Vegetables Brassicaceae as paradigm”: From Website: http//www.nucycletherapy.com/minerals/selenium/brassica.htm, pp. 1-3 (printed Jan. 2005).
“Selenium Makes the News”: From Website: http//www.medicinalfood news.com/vol01/issue2/selenium.htm, pp. 1-2 (printed Jan. 2005).
The Journal of the Chemical Society, No. 3, 1961, pp. 2890-2902.
Chimica Therapeutica, Societe D'Etudes de Chimie Therapeutique, FR., vol. 2., No. 1, 1967, pp. 39-48.

Affiliated with

Also associated with

Rating

Thyroid receptor antagonists for the treatment of cardiac... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thyroid receptor antagonists for the treatment of cardiac..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thyroid receptor antagonists for the treatment of cardiac... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3944105